AI-generated summary
The authors report a 12-week nonrandomized pilot trial of 25 people with diabetes and lower limb wounds, comparing photobiomodulation applied weekly with hydrogel alone. They found no statistically significant between-group difference in wound area, though wound area changed significantly over time in the photobiomodulation group, and no between-group difference in cytokine expression. The study was small and nonrandomized, so the authors describe the evidence as preliminary.
- Participants
- 25
- Who or what was studied
- People aged over 18 with diabetes mellitus and lower limb wounds smaller than 100 cm2
- Limits stated in the abstract
- The trial was a small, nonrandomized pilot study, so its findings are preliminary and not suitable for firm conclusions about effectiveness.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on hmpgloballearningnetwork.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Pilot study, Photobiomodulation therapy, Control group, Wound healing, Inflammation, Fluence, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.